Page 129 - THE EVOLUTION OF EARLY ARTHRITIS AND CARDIOVASCULAR RISK Samina A. Turk

REFERENCES
1. URL: http://www.who.int (accessed June 2017).
2. URL: http://www.scoremeter.nl (accessed June 2017).
3. URL: https://heartscore.escardio.org/2012/calc.aspx. (accessed June 2017).
4. Arts EE, Popa C, Den Broeder AA, Semb AG, Toms T, Kitas GD, et al. Performance of
four current risk algorithms in predicting cardiovascular events in patients with early
rheumatoid arthritis. Ann Rheum Dis 2015;74:668-74.
5. Bonek K, Gluszko P. Cardiovascular risk assessment in rheumatoid arthritis - controversies
and the new approach. Reumatologia 2016;54:128-35.
6. Baghdadi LR, Woodman RJ, Shanahan EM, Mangoni AA. The impact of traditional
cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid
arthritis: a systematic review and meta-analysis. PLoS One 2015;10:e0117952.
7. Galarza-Delgado DA, Azpiri-Lopez JR, Colunga-Pedraza IJ, Cardenas-de la Garza JA, Vera-Pineda R, Serna-Pena G, et al. Assessment of six cardiovascular risk calculators in Mexican mestizo patients with rheumatoid arthritis according to the EULAR 2015/2016 recommendations for cardiovascular risk management. Clin Rheumatol 2017;36:1387-
93.
8. Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJ, et al. EULAR
recommendations for cardiovascular disease risk management in patients with 6 rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update.
Ann Rheum Dis 2017;76:17-28.
9. Bale BF, Doneen AL, Vigerust DJ. High-risk periodontal pathogens contribute to the pathogenesis of atherosclerosis. Postgrad Med J 2017;93:215-20.
10. Bender P, Burgin WB, Sculean A, Eick S. Serum antibody levels against Porphyromonas gingivalis in patients with and without rheumatoid arthritis - a systematic review and meta-analysis. Clin Oral Investig 2017;21:33-42.
11. LahiriM,LubenRN,MorganC,BunnDK,MarshallT,LuntM,etal.Usinglifestylefactors to identify individuals at higher risk of inflammatory polyarthritis (results from the European Prospective Investigation of Cancer-Norfolk and the Norfolk Arthritis Register- -the EPIC-2-NOAR Study). Ann Rheum Dis 2014;73:219-26.
12. MahmoudiM,AslaniS,FadaeiR,JamshidiAR.Newinsightstothemechanismsunderlying atherosclerosis in rheumatoid arthritis. Int J Rheum Dis 2017;20:287-97.
13. Rosenstein ED, Greenwald RA, Kushner LJ, Weissmann G. Hypothesis: the humoral immune response to oral bacteria provides a stimulus for the development of rheumatoid arthritis. Inflammation 2004;28:311-8.
14. ArtsEE,FransenJ,DenBroederAA,PopaCD,VanRielPL.Theeffectofdiseaseduration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients. Ann Rheum Dis 2015;74:998-1003.
15. Libby P, Ridker PM. Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. Am J Med 2004;116 Suppl 6A:9S-16S.
CHANGE IN CARDIOVASCULAR RISK
127